Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2026 Filed Feb 10, 2026 22:50 UTC |
Patel BhavikSee Remarks
|
GrantCommon Stock | 4,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-006964 · wk-form4_1770763843.xml · nonDerivative · entry 1 Patel Bhavik · CIK 0002023629 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,123 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:48 UTC |
STAUB W RICHARDSee Remarks
|
Tax withholdingCommon Stock | 806 | $187.49 | $151,116.94 |
DisclosureSEC source: 0001628280-26-006961 · wk-form4_1770763727.xml · nonDerivative · entry 2 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,812 Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:48 UTC |
STAUB W RICHARDSee Remarks
|
GrantCommon Stock | 2,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-006961 · wk-form4_1770763727.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,618 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:54 UTC |
Haas BerndSee Remarks
|
Tax withholdingCommon Stock | 440 | $187.49 | $82,495.60 |
DisclosureSEC source: 0001628280-26-006972 · wk-form4_1770764071.xml · nonDerivative · entry 2 Haas Bernd · CIK 0002104344 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,414 Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:54 UTC |
Haas BerndSee Remarks
|
GrantCommon Stock | 8,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-006972 · wk-form4_1770764071.xml · nonDerivative · entry 1 Haas Bernd · CIK 0002104344 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,854 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13 and May 10, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:53 UTC |
Grenfell AlistairSee Remarks
|
Tax withholdingCommon Stock | 5,545 | $187.49 | $1,039,632.05 |
DisclosureSEC source: 0001628280-26-006970 · wk-form4_1770764008.xml · nonDerivative · entry 2 Grenfell Alistair · CIK 0002104640 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,124 Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:53 UTC |
Grenfell AlistairSee Remarks
|
GrantCommon Stock | 11,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-006970 · wk-form4_1770764008.xml · nonDerivative · entry 1 Grenfell Alistair · CIK 0002104640 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,669 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:52 UTC |
Fedock Michael J.See Remarks
|
Tax withholdingCommon Stock | 2,420 | $187.49 | $453,725.80 |
DisclosureSEC source: 0001628280-26-006967 · wk-form4_1770763958.xml · nonDerivative · entry 3 Fedock Michael J. · CIK 0002103784 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,595 Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:52 UTC |
Fedock Michael J.See Remarks
|
GrantCommon Stock | 6,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-006967 · wk-form4_1770763958.xml · nonDerivative · entry 2 Fedock Michael J. · CIK 0002103784 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,015 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13 and May 10, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:49 UTC |
Sherbet EricSee Remarks
|
Tax withholdingCommon Stock | 1,915 | $187.49 | $359,043.35 |
DisclosureSEC source: 0001628280-26-006963 · wk-form4_1770763788.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,999 Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:49 UTC |
Sherbet EricSee Remarks
|
GrantCommon Stock | 6,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-006963 · wk-form4_1770763788.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,914 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:45 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 6,801 | $187.49 | $1,275,119.49 |
DisclosureSEC source: 0001628280-26-006952 · wk-form4_1770763520.xml · nonDerivative · entry 2 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,103 Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:45 UTC |
Bruehlman Ronald ESee Remarks
|
GrantCommon Stock | 16,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-006952 · wk-form4_1770763520.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,904 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:44 UTC |
Berkshire James G.See Remarks
|
Tax withholdingCommon Stock | 1,280 | $187.49 | $239,987.20 |
DisclosureSEC source: 0001628280-26-006951 · wk-form4_1770763457.xml · nonDerivative · entry 2 Berkshire James G. · CIK 0002103773 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,177 Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:44 UTC |
Berkshire James G.See Remarks
|
GrantCommon Stock | 2,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-006951 · wk-form4_1770763457.xml · nonDerivative · entry 1 Berkshire James G. · CIK 0002103773 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,457 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:43 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 28,399 | $187.49 | $5,324,528.51 |
DisclosureSEC source: 0001628280-26-006950 · wk-form4_1770763382.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 835,941 Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:43 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 57,177 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-006950 · wk-form4_1770763382.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 864,340 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 22:52 UTC |
Fedock Michael J.See Remarks
|
Tax withholdingCommon Stock | 111 | $187.49 | $20,811.39 |
DisclosureSEC source: 0001628280-26-006967 · wk-form4_1770763958.xml · nonDerivative · entry 1 Fedock Michael J. · CIK 0002103784 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,280 Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 22:04 UTC |
Fedock Michael J.See Remarks
|
Tax withholdingCommon Stock | 381 | $239.76 | $91,348.56 |
DisclosureSEC source: 0001628280-26-004415 · wk-form4_1769810673.xml · nonDerivative · entry 1 Fedock Michael J. · CIK 0002103784 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,391 Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 22:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 50,000 | $59.90 Strike: $59.90 | $2,995,000.00 |
DisclosureSEC source: 0001628280-25-058339 · wk-form4_1766181651.xml · derivative · entry 5 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2026-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 22:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
Disposition to issuerCommon Stock | 13,436 | $222.91 | $2,995,018.76 |
DisclosureSEC source: 0001628280-25-058339 · wk-form4_1766181651.xml · nonDerivative · entry 3 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 807,163 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2026. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 22:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 36,564 | $222.43 | $8,132,930.52 |
DisclosureSEC source: 0001628280-25-058339 · wk-form4_1766181651.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 820,599 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.28 to $222.79, inclusive. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 22:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
Exercise / conversionCommon Stock | 50,000 | $59.90 | $2,995,000.00 |
DisclosureSEC source: 0001628280-25-058339 · wk-form4_1766181651.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 857,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2026. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 22:00 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 158 | $210.12 | $33,198.96 |
DisclosureSEC source: 0001628280-25-050699 · wk-form4_1762552804.xml · derivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,772 Underlying: Common Stock · 158 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 22:02 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 146 | $210.12 | $30,677.52 |
DisclosureSEC source: 0001628280-25-050703 · wk-form4_1762552918.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,735 Underlying: Common Stock · 146 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 22:01 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 181 | $210.12 | $38,031.72 |
DisclosureSEC source: 0001628280-25-050702 · wk-form4_1762552880.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,702 Underlying: Common Stock · 181 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 22:00 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 193 | $210.12 | $40,553.16 |
DisclosureSEC source: 0001628280-25-050700 · wk-form4_1762552842.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,063 Underlying: Common Stock · 193 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:01 UTC |
Sherbet EricSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 10,000 | $131.82 Strike: $131.82 | $1,318,200.00 |
DisclosureSEC source: 0001679512-25-000006 · wk-form4_1761944488.xml · derivative · entry 4 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,436 Underlying: Common Stock · 10,000 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:01 UTC |
Sherbet EricSee Remarks
|
Disposition to issuerCommon Stock | 6,000 | $219.72 | $1,318,320.00 |
DisclosureSEC source: 0001679512-25-000006 · wk-form4_1761944488.xml · nonDerivative · entry 3 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,108 Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:01 UTC |
Sherbet EricSee Remarks
|
SaleCommon Stock | 4,000 | $219.70 | $878,800.00 |
DisclosureSEC source: 0001679512-25-000006 · wk-form4_1761944488.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,108 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.66 to $219.92, inclusive. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:01 UTC |
Sherbet EricSee Remarks
|
Exercise / conversionCommon Stock | 10,000 | $131.82 | $1,318,200.00 |
DisclosureSEC source: 0001679512-25-000006 · wk-form4_1761944488.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 77,592 | $59.90 Strike: $59.90 | $4,647,760.80 |
DisclosureSEC source: 0001184180-25-000006 · wk-form4_1761944438.xml · derivative · entry 10 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 77,592 shares Expires 2026-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
Disposition to issuerCommon Stock | 21,035 | $220.96 | $4,647,893.60 |
DisclosureSEC source: 0001184180-25-000006 · wk-form4_1761944438.xml · nonDerivative · entry 8 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 807,163 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2026. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 3,973 | $221.97 | $881,886.81 |
DisclosureSEC source: 0001184180-25-000006 · wk-form4_1761944438.xml · nonDerivative · entry 7 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 828,198 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2026. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.82 to $222.27, inclusive. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 26,128 | $221.31 | $5,782,387.68 |
DisclosureSEC source: 0001184180-25-000006 · wk-form4_1761944438.xml · nonDerivative · entry 6 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 832,171 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2026. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.77 to $221.72, inclusive. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 4,600 | $220.11 | $1,012,506.00 |
DisclosureSEC source: 0001184180-25-000006 · wk-form4_1761944438.xml · nonDerivative · entry 5 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 858,299 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2026. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.74 to $220.62, inclusive. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 13,741 | $219.29 | $3,013,263.89 |
DisclosureSEC source: 0001184180-25-000006 · wk-form4_1761944438.xml · nonDerivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 862,899 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.73 to $219.66, inclusive. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 7,315 | $218.32 | $1,597,010.80 |
DisclosureSEC source: 0001184180-25-000006 · wk-form4_1761944438.xml · nonDerivative · entry 3 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 876,640 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2026. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.73 to $218.70, inclusive. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 800 | $217.58 | $174,064.00 |
DisclosureSEC source: 0001184180-25-000006 · wk-form4_1761944438.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 883,955 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.70 to $217.70, inclusive. Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 21:00 UTC |
BOUSBIB ARIDirector · See Remarks
|
Exercise / conversionCommon Stock | 77,592 | $59.90 | $4,647,760.80 |
DisclosureSEC source: 0001184180-25-000006 · wk-form4_1761944438.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 884,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2026. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 21:03 UTC |
Cherofsky KeriannSee Remarks
|
Tax withholdingCommon Stock | 35 | $197.76 | $6,921.60 |
DisclosureSEC source: 0001478242-25-000121 · wk-form4_1753909426.xml · nonDerivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,875 Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 21:04 UTC |
Patel BhavikSee Remarks
|
Tax withholdingCommon Stock | 84 | $197.76 | $16,611.84 |
DisclosureSEC source: 0001478242-25-000122 · wk-form4_1753909469.xml · nonDerivative · entry 1 Patel Bhavik · CIK 0002023629 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,040 Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:02 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 149 | $200.82 | $29,922.18 |
DisclosureSEC source: 0001478242-25-000115 · wk-form4_1753736482.xml · derivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,614 Underlying: Common Stock · 149 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:04 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 137 | $200.82 | $27,512.34 |
DisclosureSEC source: 0001478242-25-000118 · wk-form4_1753736651.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,589 Underlying: Common Stock · 137 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:03 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 174 | $200.82 | $34,942.68 |
DisclosureSEC source: 0001478242-25-000117 · wk-form4_1753736611.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,521 Underlying: Common Stock · 174 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:03 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 187 | $200.82 | $37,553.34 |
DisclosureSEC source: 0001478242-25-000116 · wk-form4_1753736580.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,870 Underlying: Common Stock · 187 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 23, 2025 Filed Jul 25, 2025 21:01 UTC |
Cherofsky KeriannSee Remarks
|
SaleCommon Stock | 549 | $191.53 | $105,149.97 |
DisclosureSEC source: 0001478242-25-000110 · wk-form4_1753477296.xml · nonDerivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,910 Read SEC document |
| July 23, 2025 Filed Jul 25, 2025 21:00 UTC |
Sherbet EricSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 11,870 | $97.20 Strike: $97.20 | $1,153,764.00 |
DisclosureSEC source: 0001478242-25-000109 · wk-form4_1753477250.xml · derivative · entry 4 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,870 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2025 Filed Jul 25, 2025 21:00 UTC |
Sherbet EricSee Remarks
|
Disposition to issuerCommon Stock | 6,070 | $190.10 | $1,153,907.00 |
DisclosureSEC source: 0001478242-25-000109 · wk-form4_1753477250.xml · nonDerivative · entry 3 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,108 Read SEC document |
| July 23, 2025 Filed Jul 25, 2025 21:00 UTC |
Sherbet EricSee Remarks
|
SaleCommon Stock | 5,800 | $190.05 | $1,102,290.00 |
DisclosureSEC source: 0001478242-25-000109 · wk-form4_1753477250.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,178 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.99 to $190.18, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.